24 results on '"Ong, Tuyen"'
Search Results
2. A novel functional gene delivery platform based on a commensal human anellovirus demonstrates transduction in multiple tissue types
3. Genetic testing and diagnosis of inherited retinal diseases
4. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR
5. A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
6. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
7. Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease
8. Anellovirus Structure Reveals a Mechanism for Immune Evasion
9. Human anelloviruses produced by recombinant expression of synthetic genomes
10. Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
11. Retinal gene therapy in X-linked retinitis pigmentosa caused by mutations in RPGR: Results at 6 months in a first in human clinical trial
12. Global genome analysis reveals a vast and dynamic anellovirus landscape within the human virome
13. Gene Therapy Proof-of-Concept in Choroideremia: meta-analysis of NSR-REP1 Phase 1/2 Clinical Trials
14. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
15. ACT DMD: Effect of Ataluren on Timed Function Tests (TFTs) in Nonsense Mutation Duchenne Muscular Dystrophy (P3.163)
16. Results of North Star Ambulatory Assessments (NSAA) in the Phase 3 Ataluren Confirmatory Trial in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (ACT DMD) (I15.008)
17. Ataluren Confirmatory Trial in DMD: Effect of Ataluren on Activities of Daily Living in Nonsense Mutation Duchenne Muscular Dystrophy (P5.002)
18. Ataluren: An Overview of Clinical Trial Results in Nonsense Mutation Duchenne Muscular Dystrophy (P3.162)
19. Results of North Star Ambulatory Assessments (NSAA) in the Phase 3 Ataluren Confirmatory Trial in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (ACT DMD) (S28.002)
20. Safety and Tolerability of Ataluren in a Phase 3 Study of Patients with Nonsense Mutation Duchenne Muscular Dystrophy (P3.164)
21. A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
22. Prolonged Exposure to Loteprednol Etabonate in Human Tear Fluid and Rabbit Ocular Tissues Following Topical Ocular Administration of Lotemax Gel, 0.5%
23. Blinding keratoconjunctivitis and child abuse
24. POSTERIOR SCLERITIS PRESENTING WITH ANNULAR CHOROIDAL DETACHMENT AS A COMPLICATION OF HERPES ZOSTER OPHTHALMICUS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.